NEWS: "Hot Off the Press"
- ZenaTech’s ZenaDrone Subsidiary to Conduct Meetings with Members of Congress Highlighting its Drone Innovation Followed by Showcasing Drone Solutions at the AUVSI Defense Forum
- Water Tower Research Highlights Alpha Modus (NASDAQ: AMOD) as the “Backbone of AI-Driven Retail Intelligence”
- Alpha Modus Files Patent Infringement Lawsuit Against Lowe’s for Unauthorized Use of AI Retail Technology
- Drone Delivery in the Shipping Industry
- ZenaTech Strengthens Drone as a Service (DaaS) Business for Government and Aviation Markets by Signing an Offer to Acquire a Second Jacksonville, Fla. Land Survey Firm
- The Ultimate Guide to Drone Inspection
- Drone Beyond Visual Line of Sight (BVLOS)
- Jonathan Javitt, MD, MPH, Founder, Chairman, and Chief Scientist of NRx Pharmaceuticals, presents at Noble Capital Markets Virtual Emerging Growth Conference
- Alpha Modus Escalates Patent Enforcement Offensive Targeting Global Retail Tech Giants
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
- Affluence Subsidiary Diprotech, Part of MTi Group, Selected by Navantia to Equip Crane Systems with IoT Sensors in New Digitalization Contract
- Alpha Modus (NASDAQ: AMOD) Ranked #10 on Insider Monkey’s Oversold Tech Stocks to Watch
- From Centralized Control to Sovereign Systems: Rethinking Energy, Intelligence and Infrastructure for the IoT, AI Revolution
- Alpha Modus Launches Patent Infringement Suit Against RetailNext – Targeting Use of AI Technologies in Global Retail Analytics
- Affluence Corporation Subsidiary MTi and Aerodyne Group Form Strategic Partnership
- Information Security Strategies That Actually Work Because They’re Built for Change
- Affluence Corporation Issues Shareholder Letter Highlighting Post-Merger Financial Performance, Restructuring Progress, and Uplisting Strategy
- Affluence Corporation Strengthens Acquisition Strategy to Drive Scalable Growth
- What Are Managed IT Services?
- AI Chatbots: A Transformative Market Set to Soar Beyond 2026
- Dr. Jonathan Javitt, Founder, Chairman and CEO of NRx Pharmaceuticals, was interviewed for a broadcast hosted by AdvisorShares.
